Pattern of proton pump inhibitor calls to Texas poison centers, 1998-2004

Mathias B Forrester1

  • 1Epidemiology and Disease Surveillance Unit, Texas Department of State Health Services, Austin, Texas 78756, USA. mathias.forrester@dshs.state.tx.us

Insights

Most proton pump inhibitor exposures, especially in children, can be safely managed at home. This study analyzed 2943 reported exposures, finding favorable outcomes in most cases.

Area of Science:

  • Toxicology
  • Pharmacology
  • Public Health

Background:

  • Limited data exists on managing adverse proton pump inhibitor (PPI) exposures.
  • PPIs are widely used medications, increasing the potential for accidental exposures.
  • Understanding exposure patterns is crucial for developing effective management strategies.

Purpose of the Study:

  • To analyze the distribution and characteristics of proton pump inhibitor exposures reported to Texas poison control centers.
  • To compare pediatric and adult patient demographics, exposure circumstances, and outcomes.
  • To identify trends in PPI-related adverse events and their management.

Main Methods:

  • Retrospective analysis of 2943 proton pump inhibitor exposure cases reported to Texas poison control centers from 1998 to 2004.
  • Categorization of exposures by patient age (pediatric vs. adult), substance involved (PPI alone vs. co-exposures), and other demographic and clinical factors.
  • Comparison of clinical characteristics and management outcomes between pediatric and adult populations.

Main Results:

  • Proton pump inhibitor (PPI) exposures accounted for a significant number of reported cases, with 62% involving PPIs alone.
  • Pediatric patients (age <= 5 years) constituted the majority (66%) of PPI-alone exposures.
  • Significant differences were observed between pediatric and adult patients regarding gender, exposure reason, site, management, clinical outcomes, and treatments.

Conclusions:

  • The majority of potentially adverse proton pump inhibitor exposures reported to poison control centers can be successfully managed at home with favorable outcomes.
  • Age is a significant factor influencing the characteristics and management of PPI exposures.
  • Further research into specific adverse effects and targeted interventions for pediatric PPI exposures may be warranted.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...